Marquis MD plans to open its first premium concierge medical practice in Boca Raton, Florida, in August 2026, introducing a membership-based model built around longer consultations, same-day appointments, around-the-clock physician access and coordinated primary care for adults and children. The practice will operate from 660 Glades Road and will offer three membership levels, including a $5,000 annual Marquis Select plan, a $12,000 Marquis Signature plan and an invitation-only Marquis Reserve service.
The commercial proposition is straightforward: Marquis MD is asking affluent individuals and families to pay a substantial annual fee for greater access, continuity and administrative support than conventional primary care usually provides. Non-membership medical services will continue to be billed to insurance, meaning the annual payment supplements rather than replaces health coverage.
The more important question is whether the company can convert that promise of access into a consistent clinical operating model. Longer visits and smaller physician panels may create better conditions for continuity and preventive planning, but the eventual value of the service will depend on staffing, care coordination, evidence-based use of diagnostics and the practice’s ability to maintain its service standards as membership grows.
Why does the Boca Raton opening position Marquis MD beyond a conventional concierge practice?
Marquis MD is presenting the Boca Raton location as a purpose-built concierge practice rather than a traditional clinic with premium services added later. Its model combines direct physician availability with a dedicated Concierge Care Coordinator responsible for referrals, laboratory follow-ups and appointment logistics. The company also plans physician follow-up calls after visits and offers in-office laboratory services intended to provide same-day results for many tests.
This distinction matters because concierge medicine can range from relatively simple appointment-access memberships to highly integrated care-management services. Marquis MD is positioning itself toward the more operationally intensive end of that spectrum, where the membership proposition includes not only additional physician time but also active navigation across specialists, diagnostics and hospital care.
The inclusion of Marquis MD Pediatrics could strengthen that proposition. Parents and children would be able to receive care within the same practice, with the company promising coordination between physicians. For families accustomed to managing separate primary care, pediatric and specialist relationships, a single coordination point could become an important retention mechanism.
However, integrated family care is not automatically seamless care. Adult medicine and pediatrics require different clinical expertise, preventive schedules, communication practices and escalation pathways. Marquis MD will therefore need to demonstrate that its unified-family positioning is supported by appropriate physician coverage and clinical processes rather than functioning mainly as a convenience feature.
What do the $5,000 and $12,000 membership tiers reveal about the target market?
Marquis Select, priced at $5,000 annually, includes the core concierge offering, such as unlimited visits, direct physician access, in-office testing and care coordination. Marquis Signature, priced at $12,000, adds advanced diagnostics, genetic testing, longevity protocols and greater physician involvement during hospitalisation. Marquis Reserve sits above those plans as an invitation-only service, although its price and complete service scope have not been publicly specified.
Those prices place Marquis MD firmly within premium healthcare rather than the lower-cost direct primary care market. Direct primary care practices frequently charge substantially smaller monthly fees and may avoid insurance billing altogether. Concierge practices commonly retain insurance billing while charging additional fees for access, time and non-covered amenities. The American Medical Association has cautioned that these two models are often confused despite their different payment structures.
For Marquis MD, the annual fee creates predictable recurring revenue while allowing the practice to maintain smaller patient panels. The economic trade-off is that each physician must generate sufficient membership revenue from a deliberately limited group of patients to cover clinical salaries, coordinator staffing, facilities, technology and continuous availability.
The value argument will therefore depend less on the number of listed benefits and more on how frequently members use them. A healthy adult who requires one annual examination may judge the economics differently from a patient managing several specialists, recurring tests or complex medication decisions. Families purchasing adult and pediatric memberships will also evaluate the combined household cost against the time saved and coordination received.
Billing transparency will be particularly important because the annual fee does not cover every medical service. The American Medical Association’s ethics guidance states that retainer practices should clearly distinguish membership amenities from medical services reimbursed through insurance and should explain the implications of the arrangement before patients enrol.
Can smaller patient panels and 24-hour access improve care without creating execution risks?
Marquis MD’s central argument is that conventional physicians often manage large patient panels and conduct short appointments, limiting the time available for detailed conversations and follow-up. Its proposed answer is to reduce physician workload per member and provide unlimited, unhurried consultations with same-day access.
A smaller panel can create favourable conditions for continuity. Physicians may have more time to review records, discuss preventive care, coordinate referrals and recognise changes that might be overlooked in a high-volume environment. Greater accessibility may also allow members to address concerns before they become urgent.
Those potential advantages should not be treated as confirmed improvements in clinical outcomes, however. Marquis MD has not disclosed comparative patient data, quality measures, hospital utilisation results or evidence showing that its model produces better outcomes than conventional primary care. The Boca Raton practice has not yet opened, making the announcement a commercial launch plan rather than an outcome-based validation of the model.
Around-the-clock access also carries operational demands. A genuine 24-hour service requires clear on-call systems, escalation procedures, coverage during holidays and appropriate boundaries between routine communication and emergencies. Service quality could deteriorate if membership expands faster than physician and coordinator capacity.
The company is currently recruiting clinical, coordinator and operational staff for the Boca Raton flagship. Its careers material emphasises smaller patient panels, reduced administrative work and an ownership pathway for physicians, suggesting that clinician recruitment and retention are part of the business strategy rather than an incidental staffing requirement.
Why will advanced diagnostics be the most clinically sensitive part of Marquis Signature?
The Marquis Signature membership is likely to receive the greatest clinical scrutiny because it includes multi-cancer early detection screening, echocardiography, genetic testing and unspecified longevity protocols. These services could attract members seeking proactive health management, but they also require particularly careful communication regarding intended use, evidence and limitations.
Marquis MD has not publicly identified the multi-cancer early detection test it intends to offer, the laboratory providing it, the eligible patient population or its regulatory status. It would therefore be inappropriate to assume that the planned screening service has received marketing authorisation from the United States Food and Drug Administration or that it has been shown to reduce cancer mortality.
The regulatory distinction matters. Some laboratory-developed tests are offered through individual laboratories without the same premarket review applied to authorised in vitro diagnostic products. The United States Food and Drug Administration notes that tests not independently reviewed by the agency may lack its assurance regarding analytical validity, clinical validity and the communication of results.
Multi-cancer testing can also generate positive findings that require imaging, biopsies or additional specialist evaluation. False-positive results may lead to anxiety and invasive follow-up, while false-negative results could create inappropriate reassurance. The clinical value of any test therefore depends on patient selection, performance characteristics, confirmatory pathways and whether its use complements rather than displaces established screening recommendations.
Genetic testing presents similar implementation questions. Hereditary risk testing is not interchangeable with testing for the presence of an existing cancer, and results can have implications for relatives as well as the individual tested. Marquis MD will need appropriate consent processes, interpretation standards and access to genetic counselling when clinically indicated.
Echocardiography is a well-established diagnostic tool, but its use should still be based on appropriate clinical indications rather than treated as a universal premium screening benefit. Longevity protocols will require even greater definition because the term can cover interventions ranging from evidence-based risk-factor management to services with uncertain clinical value.
The advanced-diagnostics package could become a meaningful differentiator, but only if the practice demonstrates discipline in deciding who should be tested, explaining what results mean and avoiding unsupported promises of early detection or life extension.
How could Marquis MD Pediatrics improve family retention while increasing care demands?
Marquis MD Pediatrics allows the company to target households rather than individual adult patients. A family-based model could improve continuity when children and parents require coordinated referrals, travel advice, laboratory follow-up or help navigating different specialists.
From a business perspective, pediatric services can lengthen the potential membership relationship. A practice that earns trust during childhood could retain families for years, while parents may be less willing to switch providers once medical histories and relationships are established.
The operational standard will nevertheless be demanding. Parents seeking concierge pediatrics may expect rapid access during evenings and weekends, detailed developmental guidance and close follow-up after acute illnesses. Marquis MD must balance those expectations with clinically appropriate triage and clear direction on when emergency or hospital care is necessary.
The company has not disclosed the number of pediatricians it plans to employ, anticipated panel sizes or how adult and pediatric on-call responsibilities will be structured. Those details may ultimately determine whether the family-care proposition becomes a genuine clinical advantage or a service promise that is difficult to deliver consistently.
Does hospitality-driven healthcare create a defensible business or an expensive service layer?
Marquis MD describes its model as hospitality-driven, but its long-term differentiation will need to extend beyond premium interiors and convenient scheduling. Competitors can reproduce amenities relatively quickly. Replicating trusted physician relationships, responsive coordination and consistent follow-up is harder because those capabilities depend on people, culture and operating discipline.
The company’s recurring membership revenue offers an attractive foundation, but premium service businesses can carry high fixed costs. Physician availability, care coordinators, laboratories and personalised communication all require sufficient staffing even when utilisation fluctuates. Limiting patient panels protects the member experience but also places a ceiling on revenue per physician unless membership prices rise.
This creates a delicate commercial balance. Enrolling too few members could weaken practice economics. Enrolling too many could undermine the access and attention that justify the fee. Marquis MD will need to define panel limits carefully and resist the temptation to increase volume at the expense of service quality.
There is also a broader access question. Retainer medicine can improve care conditions for patients able to pay, but it does not resolve primary care shortages for the wider community. The American Medical Association recognises retainer practices as a legitimate payment model while warning that they can raise concerns about access, continuity and fairness.
That tension does not invalidate Marquis MD’s business. It does mean the company should be precise about what it is offering. The model promises more physician time, coordination and convenience for members, not a universal solution to the structural constraints of American primary care.
What will determine whether the Boca Raton flagship can become a repeatable model?
The first measurable milestone is a successful August opening with enough physicians and care coordinators to deliver the advertised access standards. Membership enrolment will matter, but early utilisation, response times, patient retention and the reliability of referral and laboratory follow-up will provide stronger evidence of operational quality.
Marquis MD will also need transparent policies around insurance billing, hospital involvement and the scope of advanced diagnostic services. Members paying five-figure annual fees are likely to expect clarity about what is included, what produces additional charges and how the practice handles testing that leads to specialist care or further procedures.
The Boca Raton location is therefore more than a local clinic opening. It is the first real-world test of whether Marquis MD can combine premium hospitality, relationship-based medicine, pediatrics and diagnostic services without allowing commercial positioning to run ahead of clinical evidence.
Opening the doors will establish the business. Maintaining appropriate patient panels, delivering reliable access and applying advanced diagnostics responsibly will determine whether the model earns the confidence required to expand.
